All In Biotech

Drug Trial Radar · NCT03272685

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace Part of "Evaluating New Nicotine Standards for Cigarettes"

Last checked: Nov 20, 2026Latest source record: Aug 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 799 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

799

Actual

Start

Jun 1, 2018

Primary completion

Sep 30, 2022

Study completion Jan 10, 2023

Sponsor

Lead sponsor
University of MinnesotaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Duke University; University of California, San Francisco; Wake Forest University; University of Pennsylvania; Brown University
First posted
Sep 5, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette-free days in an experimental marketplace that contains VLNC cigarettes versus normal nicotine content (NNC) cigarettes.

Conditions

  • Tobacco Smoking
  • Nicotine Dependence

Interventions

  • Very Low Nicotine Content CigarettesDrug

    0.4 mg nicotine/g tobacco; 9 mg tar

  • Normal Nicotine Content CigarettesDrug

    15.8 mg nicotine/g tobacco; 9 mg tar

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cigarettes Per Day (CPD)Time frame: 7 days prior to week 12 visit
  2. Number of Smoke-free DaysTime frame: day 1 of study until day before week 12 visit

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Tobacco Research Center

    San Francisco, California

  • Tobacco Research Programs

    Minneapolis, Minnesota

  • The Center for Addiction Science and Technology

    Durham, North Carolina

  • Wake Forest Tobacco Control Center of Excellence

    Winston-Salem, North Carolina

  • Center for Interdisciplinary Research on Nicotine Addiction

    Philadelphia, Pennsylvania

  • Brown University Center for Alcohol and Addiction Studies School of Public Health

    Providence, Rhode Island

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.